Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
STANDIGM TO ATTEND BIO-EUROPE® 2022 2022-10-19 01:50
CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA 2022-10-18 20:50
Zhiyi Biotech Received Clinical Approval from U.S. FDA for SK10 in Chemotherapy-induced Diarrhea 2022-10-18 20:35
Axiomtek Unleashes IP69K/IP66-Rated 10.4" Stainless Steel Fanless Touch Panel Computer for Food Processing Industry - GOT810-316 2022-10-18 11:41
PENTAX Medical launches the C2 CryoBalloon(TM) Ablation System in Canada for the treatment of Barrett's Esophagus. 2022-10-15 03:57
Tianfu International Biocity: Build Global Bioindustry-city 2022-10-14 20:48
Fosun Pharma's MSCI ESG Rating Upgraded to A 2022-10-14 08:26
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy 2022-10-13 22:25
Research Collaboration between Prof. Antonio Gasbarrini team at Gemelli Hospital and Asian Biotech companies, Coree and Dx&Vx 2022-10-13 21:00
Harbour BioMed Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting 2022-10-13 19:05
Samsung Biologics obtains three global ISO certifications 2022-10-13 19:00
Guiyang's Wudang district shines in pharma sector 2022-10-13 10:12
Great Bay Bio Announces Official Launch of Site-Specific Integration Platform for Cell Line Development, AlfaCell® 2022-10-11 20:40
HanAll's Licensed Partner in China Enters Sublicense Agreement with CSPC to Further Accelerate Development of Batoclimab 2022-10-11 19:00
Samsung Biologics unlocks additional capacity for production at its newest Plant 4 2022-10-11 19:00
IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder 2022-10-11 19:00
Antengene Announces Upcoming Presentations at the 2022 Society for Immunotherapy of Cancer Annual Meeting 2022-10-08 10:43
First patient treated in Clarity's therapeutic prostate cancer trial 2022-10-07 21:06
HanAll's Second FcRn Inhibitor HL161ANS to be Added to the Development Program of its Licensed Partner 2022-10-04 19:00
Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry 2022-10-04 14:00
1 66 67 68 69 70 165